Global Dengue Testing Market is valued at USD 639.12 billion in 2025 to around USD 987.24 million by 2034, with a CAGR of approximately 4.95% during the forecast period. Scope of Dengue Testing Market The dengue testing refers to the ecosystem of diagnostic products and solutions used to detect dengue virus infections, including rapid diagnostic tests (RDTs), ELISA kits, PCR-based assays, and emerging molecular and biosensor technologies. These tests are used across hospitals, diagnostic laboratories, blood banks, and point-of-care settings to enable early detection, disease confirmation, and outbreak surveillance.